Singapore legislation

Regulation 10

of Health Products (Cell, Tissue and Gene Therapy Products) Regulations 2021

Regulation 10

Supplying minimally manipulated CTGT products by wholesale

Amended byS 451/2022 wef 01/07/2022

Subregulation 1

For the purposes of section 14(1) of the Act, a wholesaler’s licence is not required for the supply by wholesale of a CTGT product that is a result of only minimal manipulation of cell or tissue if the person supplying by wholesale —

(a)

is supplying the CTGT product not to the public but solely for —

(i)

the purpose of scientific education or research and development; or

(ii)

a non‑clinical purpose; or

(b)

gives notice to the Authority in accordance with paragraph (2) in relation to a CTGT product that is a result of only minimal manipulation of cell or tissue and that notice is not refused, withdrawn or cancelled under these Regulations.

Subregulation 2

Amended byS 451/2022 wef 01/07/2022

The notice required by paragraph (1)(b) for a CTGT product that is a result of only minimal manipulation of cell or tissue must —

(a)

be in the form and manner specified on the Authority’s website;

(b)

be accompanied by the following information in writing:

(i)

the particulars of the person giving the notice as required by the Authority; (ii)a description of the CTGT product to be supplied by wholesale;

(iii)

a statement of the supply by wholesale involved;

(iv)

the premises where the CTGT product is to be stored; and

(c)

be accompanied by the relevant fee.

Subregulation 3

A licensed wholesaler of any CTGT product is not required to give notice to the Authority under paragraph (1)(b) to import or supply a CTGT product that is a result of only minimal manipulation of cell or tissue.